Additionally, miR-21 has been clinically applied in gynecological cancers, including ovarian, cervical, and endometrial cancers, as it regulates the downstream target programmed cell death 4 (PDCD4) [140]. Here, PDCD4 is linked to female reproductive organ cancer.